AAPL   321.85 (+1.23%)
MSFT   182.83 (-0.23%)
FB   231.91 (+3.03%)
GOOGL   1,434.87 (+0.09%)
AMZN   2,471.04 (+1.17%)
NVDA   352.25 (-0.78%)
CGC   16.48 (-5.12%)
BABA   206.57 (-0.40%)
MU   46.34 (-3.28%)
GE   6.76 (+2.89%)
TSLA   898.10 (+7.56%)
AMD   53.63 (-0.32%)
T   30.93 (+0.23%)
ACB   14.10 (+0.14%)
F   5.87 (+2.80%)
GILD   75.16 (-3.43%)
DIS   118.77 (+1.25%)
NFLX   425.92 (+1.47%)
BAC   24.61 (+2.03%)
BA   151.39 (+3.80%)
AAPL   321.85 (+1.23%)
MSFT   182.83 (-0.23%)
FB   231.91 (+3.03%)
GOOGL   1,434.87 (+0.09%)
AMZN   2,471.04 (+1.17%)
NVDA   352.25 (-0.78%)
CGC   16.48 (-5.12%)
BABA   206.57 (-0.40%)
MU   46.34 (-3.28%)
GE   6.76 (+2.89%)
TSLA   898.10 (+7.56%)
AMD   53.63 (-0.32%)
T   30.93 (+0.23%)
ACB   14.10 (+0.14%)
F   5.87 (+2.80%)
GILD   75.16 (-3.43%)
DIS   118.77 (+1.25%)
NFLX   425.92 (+1.47%)
BAC   24.61 (+2.03%)
BA   151.39 (+3.80%)
AAPL   321.85 (+1.23%)
MSFT   182.83 (-0.23%)
FB   231.91 (+3.03%)
GOOGL   1,434.87 (+0.09%)
AMZN   2,471.04 (+1.17%)
NVDA   352.25 (-0.78%)
CGC   16.48 (-5.12%)
BABA   206.57 (-0.40%)
MU   46.34 (-3.28%)
GE   6.76 (+2.89%)
TSLA   898.10 (+7.56%)
AMD   53.63 (-0.32%)
T   30.93 (+0.23%)
ACB   14.10 (+0.14%)
F   5.87 (+2.80%)
GILD   75.16 (-3.43%)
DIS   118.77 (+1.25%)
NFLX   425.92 (+1.47%)
BAC   24.61 (+2.03%)
BA   151.39 (+3.80%)
AAPL   321.85 (+1.23%)
MSFT   182.83 (-0.23%)
FB   231.91 (+3.03%)
GOOGL   1,434.87 (+0.09%)
AMZN   2,471.04 (+1.17%)
NVDA   352.25 (-0.78%)
CGC   16.48 (-5.12%)
BABA   206.57 (-0.40%)
MU   46.34 (-3.28%)
GE   6.76 (+2.89%)
TSLA   898.10 (+7.56%)
AMD   53.63 (-0.32%)
T   30.93 (+0.23%)
ACB   14.10 (+0.14%)
F   5.87 (+2.80%)
GILD   75.16 (-3.43%)
DIS   118.77 (+1.25%)
NFLX   425.92 (+1.47%)
BAC   24.61 (+2.03%)
BA   151.39 (+3.80%)
Log in

NASDAQ:SXTCChina SXT Pharmaceuticals Stock Price, Forecast & News

$0.40
+0.01 (+2.55 %)
(As of 06/1/2020 04:00 PM ET)
Add
Compare
Today's Range
$0.38
Now: $0.40
$0.43
50-Day Range
$0.37
MA: $0.43
$0.54
52-Week Range
$0.34
Now: $0.40
$5.00
Volume2.30 million shs
Average Volume2.28 million shs
Market Capitalization$11.17 million
P/E RatioN/A
Dividend YieldN/A
Beta0.29
China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine tablets in China. It provides oral prescription drugs and supplements under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. The company offers its products to pharmaceutical distributors, pharmaceutical companies, pharmacies, and hospitals through sales representatives. China SXT Pharmaceuticals, Inc. was founded in 2005 and is based in Taizhou, China.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.2Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.57 out of 5 stars


Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:SXTC
CUSIPN/A
CIKN/A
Phone86-523-8629-8290

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$7.01 million
Cash Flow$0.08 per share
Book Value$0.49 per share

Profitability

Miscellaneous

EmployeesN/A
Market Cap$11.17 million
Next Earnings Date8/17/2020 (Estimated)
OptionableNot Optionable

Receive SXTC News and Ratings via Email

Sign-up to receive the latest news and ratings for SXTC and its competitors with MarketBeat's FREE daily newsletter.

China SXT Pharmaceuticals (NASDAQ:SXTC) Frequently Asked Questions

How has China SXT Pharmaceuticals' stock been impacted by COVID-19 (Coronavirus)?

China SXT Pharmaceuticals' stock was trading at $0.7799 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, SXTC stock has decreased by 48.4% and is now trading at $0.4027. View which stocks have been most impacted by Coronavirus.

When is China SXT Pharmaceuticals' next earnings date?

China SXT Pharmaceuticals is scheduled to release its next quarterly earnings announcement on Monday, August 17th 2020. View our earnings forecast for China SXT Pharmaceuticals.

Has China SXT Pharmaceuticals been receiving favorable news coverage?

News headlines about SXTC stock have been trending extremely negative on Monday, according to InfoTrie Sentiment. The research firm rates the sentiment of news coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. China SXT Pharmaceuticals earned a coverage optimism score of -5.0 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the company's share price in the next few days. View the latest news aboutChina SXT Pharmaceuticals.

Are investors shorting China SXT Pharmaceuticals?

China SXT Pharmaceuticals saw a increase in short interest in the month of May. As of May 15th, there was short interest totaling 562,800 shares, an increase of 25.1% from the April 30th total of 449,800 shares. Based on an average trading volume of 1,990,000 shares, the short-interest ratio is currently 0.3 days. Approximately 4.2% of the shares of the company are short sold. View China SXT Pharmaceuticals' Current Options Chain.

Who are some of China SXT Pharmaceuticals' key competitors?

What other stocks do shareholders of China SXT Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some companies that other China SXT Pharmaceuticals investors own include Gilead Sciences (GILD), HEXO (HEXO), Inovio Pharmaceuticals (INO), Amarin (AMRN), Aphria (APHA), Canopy Growth (CGC), Pfizer (PFE), Shopify (SHOP), AT&T (T) and Vaxart (VXRT).

Who are China SXT Pharmaceuticals' key executives?

China SXT Pharmaceuticals' management team includes the following people:
  • Mr. Feng Zhou, Chairman & CEO (Age 27)
  • Mr. Yao Shi, Chief Financial Officer (Age 38)
  • Dr. Jingzhen Deng, Chief Scientific Officer & COO (Age 59)
  • Mr. Jun Zheng, Exec. Director (Age 40)

What is China SXT Pharmaceuticals' stock symbol?

China SXT Pharmaceuticals trades on the NASDAQ under the ticker symbol "SXTC."

How do I buy shares of China SXT Pharmaceuticals?

Shares of SXTC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is China SXT Pharmaceuticals' stock price today?

One share of SXTC stock can currently be purchased for approximately $0.40.

How big of a company is China SXT Pharmaceuticals?

China SXT Pharmaceuticals has a market capitalization of $11.17 million and generates $7.01 million in revenue each year.

What is China SXT Pharmaceuticals' official website?

The official website for China SXT Pharmaceuticals is www.sxtchina.com.

How can I contact China SXT Pharmaceuticals?

China SXT Pharmaceuticals' mailing address is 178 TAIDONG ROAD NORTH, TAIZHOU F4, 225300. The company can be reached via phone at 86-523-8629-8290 or via email at [email protected]

This page was last updated on 6/1/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.